Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010495
Filing Date
2020-08-13
Accepted
2020-08-13 08:02:34
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pasg-20200630x10q.htm 10-Q 1425581
2 EX-10.4 pasg-20200630ex1049f486a.htm EX-10.4 617959
3 EX-31.1 pasg-20200630ex3115983af.htm EX-31.1 10828
4 EX-31.2 pasg-20200630ex3121a224d.htm EX-31.2 10720
5 EX-32.1 pasg-20200630ex321f15e4d.htm EX-32.1 5957
6 EX-32.2 pasg-20200630ex322b4a9fd.htm EX-32.2 5937
7 GRAPHIC pasg-20200630x10q001.jpg GRAPHIC 48721
  Complete submission text file 0001558370-20-010495.txt   4878850

Data Files

Seq Description Document Type Size
8 EX-101.INS pasg-20200630.xml EX-101.INS 643256
9 EX-101.SCH pasg-20200630.xsd EX-101.SCH 39212
10 EX-101.CAL pasg-20200630_cal.xml EX-101.CAL 30397
11 EX-101.DEF pasg-20200630_def.xml EX-101.DEF 127268
12 EX-101.LAB pasg-20200630_lab.xml EX-101.LAB 319463
13 EX-101.PRE pasg-20200630_pre.xml EX-101.PRE 228520
Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39231 | Film No.: 201097290
SIC: 2836 Biological Products, (No Diagnostic Substances)